Keyphrases
Leprosy
100%
Leprosy Patients
57%
Disability
42%
Indonesia
39%
Mycobacterium Leprae
35%
Leprosy Reactions
27%
Syphilis Serology
22%
PGL-I
22%
Bacterial Index
19%
M. Lepromatosis
18%
Diffuse Lepromatous Leprosy
18%
Cutaneous Wound Healing
18%
Resveratrol
18%
Conditioned Medium
18%
Chemoprophylactic
18%
Single Center
18%
Growth Factors
18%
AIDS/HIV
18%
Elementary School children
18%
Risk Factors
18%
Secondary Syphilis
18%
Erythema multiforme
18%
Unusual Presentation
18%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
18%
Umbilical Cord
18%
Lucio Phenomenon
18%
Endemic Countries
18%
Mycobacterium Lepromatosis
18%
Beneficial Effects
18%
HIV Patients
18%
Causative Agents
18%
Titer
18%
Epidemiology
18%
Ulcer
13%
Vascular Endothelial Growth Factor
12%
IgM Antibody
12%
Skin Lesions
12%
Fever
10%
Platelet-derived Growth factor-BB (PDGF-BB)
10%
Clarithromycin
10%
Rifampicin
10%
Syphilis
10%
Amplicon
9%
Histopathological Examination
9%
Epidermis
9%
DNA Sequencing
9%
RaaS
7%
Human Immunodeficiency Virus Infection
7%
Antibody Level
7%
Nontreponemal
7%
Medicine and Dentistry
Retrospective Study
54%
Diseases
38%
Human Immunodeficiency Virus
36%
Erythema Nodosum Leprosum
36%
Infection
25%
Lepromatous Leprosy
24%
Medical Record
18%
Physical Activity
18%
Immunoglobulin M Antibody
18%
Personal Experience
18%
Quality of Life
18%
Cross Sectional Study
18%
Mycobacteria
18%
Secondary Syphilis
18%
Syphilis Serology
18%
Umbilical Cord
18%
Erythema Multiforme
18%
Ulcer
18%
Polypharmacy
18%
Immunity
18%
Peripheral Nerve
18%
Public Health
18%
Venereology
18%
Dermatology
18%
Cohort Effect
18%
Syphilis
16%
Histopathology
16%
Outpatient
15%
Venereal Disease Research Laboratory Test
14%
Rifampicin
14%
Clarithromycin
14%
Mycobacterium leprae
13%
Amplicon
12%
Disease Duration
12%
Skin Defect
12%
DNA Sequence
12%
Nerve Injury
10%
Mixed Infection
8%
Nerve Malformation
6%
Eyebrow
6%
Mucosa
6%
Sensation
6%
Primigravida
6%
Wound
6%
Weakness
6%
Paralysis
6%
Blister
6%
Foam Cell
6%
Immunoglobulin G Antibody
6%
Immunoglobulin M
6%